1. Home
  2. MURA vs AMPG Comparison

MURA vs AMPG Comparison

Compare MURA & AMPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MURA
  • AMPG
  • Stock Information
  • Founded
  • MURA 2013
  • AMPG 2002
  • Country
  • MURA Ireland
  • AMPG United States
  • Employees
  • MURA N/A
  • AMPG N/A
  • Industry
  • MURA
  • AMPG Telecommunications Equipment
  • Sector
  • MURA
  • AMPG Telecommunications
  • Exchange
  • MURA Nasdaq
  • AMPG Nasdaq
  • Market Cap
  • MURA 45.8M
  • AMPG 46.7M
  • IPO Year
  • MURA N/A
  • AMPG N/A
  • Fundamental
  • Price
  • MURA $2.48
  • AMPG $2.13
  • Analyst Decision
  • MURA Strong Buy
  • AMPG Strong Buy
  • Analyst Count
  • MURA 3
  • AMPG 1
  • Target Price
  • MURA $12.00
  • AMPG $5.00
  • AVG Volume (30 Days)
  • MURA 100.7K
  • AMPG 177.0K
  • Earning Date
  • MURA 08-12-2025
  • AMPG 08-13-2025
  • Dividend Yield
  • MURA N/A
  • AMPG N/A
  • EPS Growth
  • MURA N/A
  • AMPG N/A
  • EPS
  • MURA N/A
  • AMPG N/A
  • Revenue
  • MURA N/A
  • AMPG $10,814,140.00
  • Revenue This Year
  • MURA N/A
  • AMPG $114.55
  • Revenue Next Year
  • MURA N/A
  • AMPG $50.00
  • P/E Ratio
  • MURA N/A
  • AMPG N/A
  • Revenue Growth
  • MURA N/A
  • AMPG N/A
  • 52 Week Low
  • MURA $0.95
  • AMPG $0.64
  • 52 Week High
  • MURA $4.74
  • AMPG $6.43
  • Technical
  • Relative Strength Index (RSI)
  • MURA 45.72
  • AMPG 51.21
  • Support Level
  • MURA $2.41
  • AMPG $1.89
  • Resistance Level
  • MURA $2.55
  • AMPG $2.08
  • Average True Range (ATR)
  • MURA 0.09
  • AMPG 0.12
  • MACD
  • MURA -0.01
  • AMPG -0.02
  • Stochastic Oscillator
  • MURA 28.57
  • AMPG 39.22

About MURA Mural Oncology plc

Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.

About AMPG Amplitech Group Inc.

AmpliTech Group Inc designs, develops, engineers, and assembles micro-wave component-based amplifiers that meet individual customer specifications. The products of the company consist of RF amplifiers & related subsystems, operating at multiple frequencies from 50kHz to 44GHz, including Low Noise Amplifiers, Medium Power Amplifiers, cryogenic amplifiers, and custom assemblies. The company also offers non-recurring engineering services on a project-by-project basis, for a predetermined fixed contractual amount, or on a time-plus-material basis. It also operates as a manufacturer, & distributor of cryogenic microwave amplifiers, RF designs, & applications for Wireless Networks & the future of Wireless Communication.

Share on Social Networks: